Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Duration of androgen deprivation therapy for high-risk prostate cancer: application of randomized trial data in a tertiary referral cancer center
Author: Muralidhar, V.
Regan, M.
Werner, L.
Nakabayashi, M.
Evan, C.
Bellmunt, J.
Choueiri, T.
Elfiky, A.
Harshman, L.
McKay, R.
Pomerantz, M.
Sweeney, C.
Taplin, M.
Kantoff, P.
Nguyen, P.
Citation: Clinical Genitourinary Cancer, 2016; 14(4):e299-e305
Publisher: Elsevier
Issue Date: 2016
ISSN: 1558-7673
Statement of
Vinayak Muralidhar, Meredith M. Regan, Lillian Werner, Mari Nakabayashi, Carolyn P. Evan, Joaquim Bellmunt, Toni K. Choueiri, Aymen A. Elfiky, Lauren C. Harshman, Rana R. McKay, Mark M. Pomerantz, Christopher J. Sweeney, Mary-Ellen Taplin, Philip W. Kantoff, Paul L. Nguyen
Abstract: Abstract not available
Keywords: ADT; Discontinuation; Side effects; Toxicity
Description: Epub: Dec 17, 2015
Rights: © 2016 Elsevier Inc. All rights reserved.
RMID: 0030043261
DOI: 10.1016/j.clgc.2015.12.008
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.